CORMEDIX INC WTS EXP 04/30/15
CRMD.WS
CRMD.WS was delisted on the 29th of April, 2015.
0 hedge funds and large institutions have $0 invested in CORMEDIX INC WTS EXP 04/30/15 in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $2.91M → $0 (-$2.91M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EM
Elliott Management
New York
|
-$2.5M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$275K |
| 3 |
ICM
Ionic Capital Management
New York
|
-$107K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21K |
CRMD.WS Hedge Fund Activity: Q2 2015 in Review
0 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) for Q2 2015, worth a combined $0 — down 100% from $2.91M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CRMD.WS and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Elliott Management, exiting entirely with an estimated $2.5M sold.
- 0 institutional investors held CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) as of Q2 2015, down from 4 in Q1 2015.
- Funds reported $0 of CORMEDIX INC WTS EXP 04/30/15 stock for Q2 2015, down 100% quarter-over-quarter.
- 0 funds opened new CORMEDIX INC WTS EXP 04/30/15 positions in Q2 2015 and 4 closed out, a net change of -4 holders.
- The largest CORMEDIX INC WTS EXP 04/30/15 seller in Q2 2015 was Elliott Management, an estimated $2.5M sold.
Based on aggregated 13F filings for Q2 2015.